Related Experiment Video

Updated: Oct 8, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.7K

KDM6 Demethylases and Their Roles in Human Cancers

Chunyan Hua1, Jiaqing Chen2, Shuting Li2

  • 1School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.

Frontiers in Oncology
|December 24, 2021
PubMed

Insights

KDM6 demethylases are key epigenetic regulators in cancer, acting as tumor suppressors or oncoproteins. Understanding their regulation and function offers novel therapeutic strategies for cancer prevention and treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer therapy is evolving to incorporate epigenetic strategies beyond traditional chemotherapy.
  • KDM6 demethylases play a crucial role in regulating gene expression through histone demethylation.
  • Dysregulation of KDM6 demethylases is implicated in the development of various human cancers.

Purpose of the Study:

  • To review the structural features and regulation of the KDM6 subfamily of demethylases.
  • To explore the context-dependent roles of KDM6 enzymes as tumor suppressors or oncoproteins in cancer.
  • To propose novel therapeutic strategies targeting KDM6 enzymes for cancer treatment.

Main Methods:

  • Structural analysis of KDM6 subfamily members.
  • Review of intrinsic (cellular metabolism) and extrinsic (tumor microenvironment) regulators of KDM6.
  • Analysis of KDM6 aberrant functions in human cancers.
  • Exploration of epigenetic and immunomodulatory mechanisms related to KDM6.

Main Results:

  • KDM6 regulation is influenced by both cellular metabolism and the tumor microenvironment.
  • KDM6 enzymes exhibit context-dependent functions, acting as either tumor suppressors or oncoproteins.
  • Aberrant KDM6 activity is a hallmark of various cancers.

Conclusions:

  • KDM6 demethylases represent promising therapeutic targets for cancer.
  • Targeting KDM6 based on its structural, epigenetic, and immunomodulatory properties may offer novel treatment avenues.
  • Further research into KDM6 mechanisms can provide insights for cancer prevention and therapy.
Keywords:
KDM6cancercancer therapyepigeneticshistone demethylase

More Related Videos

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

25.7K
Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.4K

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K